The landscape of hammertoe treatment is evolving, with a growing emphasis on patient-centered, less invasive, and more efficient care. This shift is creating significant opportunities for US Hammertoe Market Growth. With the market projected to expand from USD 294 million in 2024 to USD 900 million by 2035 at a CAGR of 10.71%, substantial opportunities are emerging, particularly in the fields of non-surgical therapies and the expanding role of Ambulatory Surgical Centers (ASCs). These trends are catering to patient preferences for faster recovery, reduced discomfort, and more accessible care settings.

Non-Surgical Therapies: A Fast-Growing Segment

A primary driver of US Hammertoe Market Growth is the increasing demand for non-surgical treatment options. While surgery remains the gold standard for severe cases, there is a growing patient preference for conservative management. This is driven by a desire to avoid the risks and recovery time associated with surgery. The Flexible treatment segment is experiencing rapid growth as patients seek comfortable, adaptable solutions for symptom management. Furthermore, the introduction of new custom orthotic devices, such as those launched by Zimmer Biomet, is providing effective non-invasive alternatives . Physical therapy, pharmacological interventions, and specialized footwear are also gaining traction, supported by growing clinical evidence of their effectiveness. This shift towards holistic, non-invasive care is a major trend, opening new avenues for product innovation and market expansion.

The Rise of Ambulatory Surgical Centers

Another major avenue for US Hammertoe Market Growth is the rapid expansion of Ambulatory Surgical Centers (ASCs). The US healthcare system is increasingly shifting towards outpatient care to reduce costs and improve patient convenience. ASCs offer a more efficient and cost-effective setting for many surgical procedures, including hammertoe correction. These centers are specialized in high-volume, low-acuity procedures and can perform surgeries at a lower cost than traditional hospitals. The rise of ASCs is directly benefiting the hammertoe market, as they are a primary setting for foot and ankle surgeries . The demand for implants and instruments that are optimized for ASC use—such as procedural kits that include all necessary disposables for a single case—is growing, creating opportunities for manufacturers to develop and market products tailored to this setting .

Technological Advancements and Patient Preference

The growth in non-surgical and ASC-based care is being fueled by technological advancements and shifting patient preferences. Minimally invasive surgical techniques, which are often performed in ASCs, offer patients quicker recovery times, less pain, and smaller scars. This makes surgery a more appealing option for those who might have previously delayed treatment. Furthermore, the development of advanced orthotic devices and wearable technologies is empowering patients to manage their condition more proactively. The integration of digital health tools, such as telemedicine for consultations and follow-ups, is also enhancing patient access and engagement. These factors are collectively driving the demand for a broader range of treatment options, from conservative management to efficient surgical interventions.

Strategic Focus on ASCs and Innovative Products

To capitalize on these growth opportunities, companies are increasingly focusing their strategies on the ASC market. This involves developing products that are specifically designed for the ASC environment, such as single-use procedural kits that simplify logistics and reduce costs. There is also a growing emphasis on surgeon education and training to support the adoption of new techniques in these settings. Partnerships and collaborations, such as the one between Zimmer Biomet and a digital health company for AI-driven planning, are aimed at streamlining surgical procedures and improving outcomes . As the market continues to evolve, companies that can effectively serve the ASC and non-surgical segments will be well-positioned to capture significant market share in this rapidly growing market.